Corporation BioVaxys Receives Management Cease Trade Order from British Columbia Securities CommissionMarch 4, 2025 BioVaxys Technology Corp. has received a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements.